- Home
- AAME vs BRNS Comparison
AAME vs BRNS Comparison
Compare AAME & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAME
- BRNS
- Stock Information
- Founded
- AAME 1968
- BRNS 2016
- Country
- AAME United States
- BRNS United Kingdom
- Employees
- AAME N/A
- BRNS N/A
- Industry
- AAME Life Insurance
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- AAME Finance
- BRNS Health Care
- Exchange
- AAME Nasdaq
- BRNS Nasdaq
- Market Cap
- AAME 27.1M
- BRNS 28.2M
- IPO Year
- AAME N/A
- BRNS 2021
- Fundamental
- Price
- AAME $1.81
- BRNS $0.87
- Analyst Decision
- AAME
- BRNS Strong Buy
- Analyst Count
- AAME 0
- BRNS 2
- Target Price
- AAME N/A
- BRNS $3.00
- AVG Volume (30 Days)
- AAME 20.1K
- BRNS 32.3K
- Earning Date
- AAME 05-20-2025
- BRNS 05-07-2025
- Dividend Yield
- AAME 1.10%
- BRNS N/A
- EPS Growth
- AAME N/A
- BRNS N/A
- EPS
- AAME N/A
- BRNS N/A
- Revenue
- AAME $188,227,000.00
- BRNS $14,969,000.00
- Revenue This Year
- AAME N/A
- BRNS N/A
- Revenue Next Year
- AAME N/A
- BRNS N/A
- P/E Ratio
- AAME N/A
- BRNS N/A
- Revenue Growth
- AAME 0.77
- BRNS 4381.74
- 52 Week Low
- AAME $1.25
- BRNS $0.64
- 52 Week High
- AAME $1.99
- BRNS $2.45
- Technical
- Relative Strength Index (RSI)
- AAME 69.34
- BRNS 48.03
- Support Level
- AAME $1.52
- BRNS $0.87
- Resistance Level
- AAME $1.60
- BRNS $1.02
- Average True Range (ATR)
- AAME 0.12
- BRNS 0.12
- MACD
- AAME 0.04
- BRNS 0.01
- Stochastic Oscillator
- AAME 88.82
- BRNS 36.63
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.